Hydroxy Tipelukast-d6 Sodium Salt
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Hydroxy Tipelukast-d6 Sodium Salt Product Information
Hydroxy Tipelukast-d6 Sodium Salt is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-99202.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Hydroxy Tipelukast-d6 Sodium Salt
CAT No.
CS-T-99202
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C29H33D6NaO7S
Molecular Weight
560.71
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Hydroxy Tipelukast-d6 Sodium Salt is supplied with detailed characterization data compliant with regulatory guideline. Hydroxy Tipelukast-d6 Sodium Salt can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Hydroxy Tipelukast-d6 Sodium Salt has shown to improve symptoms of fatty liver, lobular inflammation hepatocyte hypertrophy and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH)."
Synonyms
Hydroxy Tipelukast-d6 Sodium Salt
Application Notes
"Hydroxy Tipelukast-d6 Sodium Salt has shown to improve symptoms of fatty liver, lobular inflammation hepatocyte hypertrophy and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH)."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.